The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence ...
Both of these GLP-1 drugs were originally designed for diabetes, but their benefits keep expanding — KSTP health expert Dr.
The global sleep apnea devices market is set to expand at a steady CAGR of 9.5%, growing from USD 8.2 billion in 2023 to USD ...
On today’s CT BUZZ, Host Natasha Lubczenko sat down with Dr. Zach Korwin, owner of Sleep Stratford, to discuss an innovative ...
According to statistics by the American Association of Medicine, the disorder sleep apnea affects approximately 30 million US ...
For patients with obstructive sleep apnea (OSA), sleep surgery is associated with a significantly reduced risk for mo ...
Discover the link between REM sleep and Alzheimer's disease. Learn how delayed REM sleep may indicate elevated protein levels ...
The treatment has become increasingly popular, especially among older men. Here is what to keep in mind if you are ...
Key Takeaways Untreated sleep apnea contributes to car crashesPatients who got no treatment were 21% more likely to be in a ...
FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.
One of the best-understood connections between sleep position and heart and brain health involves sleep apnea, where ...
Learn how sleep plays a vital role in regulating blood pressure and preventing hypertension, offering new ways to manage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback